Update From ASCO: Advances in Immunotherapy for Non-Small Cell Lung Cancer and Melanoma




Release Date: August 29, 2014 Expiration Date: August 29, 2015
Medium: Print with online posttest, evaluation, and request for credit

Overview

The 2014 American Society of Clinical Oncology (ASCO) Annual Meeting, widely regarded as the world's foremost event in oncology, convened on May 29 in Chicago, IL, where developments in immuno-oncology took center stage. Gains made in understanding tumor biology, immunology, and the underlying mechanisms of immunity in cancer have spurred the development of an increasingly broad range of immunotherapies, for an increasingly broad range of cancers. This activity will review key presentations in non-small cell lung cancer and melanoma.  Commentary from a community-based medical oncologist will provide insight into how immunotherapy can have unique toxicities, and varying response times for different patients, contributing to important factors for determining appropriate patient selection.

Instructions For This Activity

  • Read the article in its entirety.

Instructions For Receiving Credit

  • In order to receive a CME certificate, participants must complete the posttest and pass with a score of 70% or higher, complete the evaluation, and request for credit. Participants may immediately download a CME certificate upon completion of these steps.


Target Audience

This activity is directed toward medical oncologists and hematologists who treat patients with solid tumors and hematologic malignancies.  Fellows, nurses, physician assistants, nurse practitioners, and other healthcare providers may also participate.


Learning Objectives

After participating in this CME activity, learners should be better prepared to:
  • Review recent data on immunotherapies presented at national society meetings


Accreditation/ Credit Designation

Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

No commercial support was received for this CME-certified activity. This activity is funded entirely by Physicians’ Education Resource®, LLC.


Faculty Author/Planner

Abraham Schwarzberg, MD
Chief of Oncology
Jupiter Medical Center
Managing Member, Cancer Center of South Florida

Disclosures: No relevant financial relationships with commercial interests to disclose.

Medical Writer

Kathleen Krafton
Disclosure: No relevant financial relationships with commercial interests to disclose.

The American Journal of Hematology/Oncology Editorial Board Members

Debu Tripathy, MD
Professor of Medicine
University of Southern California
Norris Comprehensive Cancer Center
Los Angeles, CA

Disclosure: Grant/Research Support: Genentech/ Roche, Pfizer, Puma, Inc. (clinical trial support contracted to University of Southern California); Consultant: Eisai, Novartis

Staff/Planner Disclosures and Conflict of Interest Resolution

The staffs of PER® (Debbie Augustus, Ann C. Lichti, CCMEP and Megan O'Connell) as well as the Editorial Staff of The American Journal of Hematology/Oncology (Devera Pine) have no relevant financial relationships with commercial interests to disclose.

In accordance with ACCME's Standards for Commercial SupportSM, PER® resolved all conflicts of interest (COI) prior to the release of this CME activity using a multistep process.


Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only, and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.


Disclaimer

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of Physicians' Education Resource®, LLC.


Hardware And Software Requirements

Supported Browsers
Internet Explorer v.7 or greater (for Windows) | Mozilla Firefox v.2 or greater (for Windows, Mac, Linux)

Minimum System Requirements (Windows)
  • A Pentium-based PC or compatible computer
  • At least 64MB of RAM
  • Windows 95/98/NT/ME/2000/XP/Vista system software
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise
Minimum System Requirements (Mac OS)
  • A PowerPC processor-based Macintosh computer
  • At least 64MB of RAM
  • Mac OS 7.5 or later
  • Screen resolution of 1024 x 786 or larger recommended
PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise


Contact information for questions about the activity:

Physicians’ Education Resource®, LLC (PER®)
666 Plainsboro Road, Suite 356
Plainsboro, NJ 08536
Phone: (888) 949-0045
E-mail: info@gotoper.com

Calendar of Events
SUNMONTUESWEDTHURSFRISAT
   1234
567891011
12131415161718
19202122232425
262728
Filter By

VSEO N/A